PPT-Assessment & Intervention of Amyotrophic Lateral Sclerosis (ALS)

OT 510515 Rachel Rombalski Amy Londry Rachel Csatari Alyssa Kolanowski Introduction Brief overview of ALS Stages of ALS Case Study Roberto Areas of Occupation Affected Role of Occupational Therapy in Treating . Presented by Alexia DeLara, Vanesa Mesic, . Joseph Ekofo, Amber . Tinagero, . and Jerilyn Curtis. What is ALS?. ALS is a rapidly progressive idiopathic neurodegenerative disease primarily targeting voluntary motor neurons, which may result in muscle weakness, paralysis, and respiratory failure. ‘. where in the CNS’. Lauren . O’Flynn. Learning objectives. Definition of CNS and PNS. Definition of UMN and LMN. Function of each of the cerebral lobes. The homunculus. Circle of . willis. and blood supply to the cerebral hemispheres. Autoimmune disease . Affects 2.3 million people in the world. 3 Types. Relapsing-. remmitting. Primary-progressive. Secondary-progressive. Chronic . . https://www.gofundme.com/helpmarcusbeatms. What is the epidemiology of MS?. Introduction of Case Study. In this case the person is multiple Sclerosis patient. She is about 34 years of age.. Patient feels that her left body portion is relatively weak, massive fatigue with a potential . 2519Jeff Redleene S1 Heber Anandan2 Alagesan S3 Lakshmi4 Manikandan4 Grashia4CASE REPORTIntroduction Balos concentric sclerosis is a rare demyelinating disease that was x00660069rst described by Josze Finding Uplifting Solutions. Timothy Sheehy – Physiotherapist. State-wide . Progressive Neurological Diseases . Service (SPNDS). Calvary Health Care . Bethlehem, Melbourne Victoria. Background. Incidence . on the Unfolded . Protein . Response OF The VAPB protein. Keerthana Vishwanath. Amyotrophic Lateral Sclerosis (ALS). What is ALS?. What are the two types of ALS?. ALS is typically caused by mutation. Cynthia Wang, MD. UT Southwestern Medical Center . Children’s Health Dallas. Disclosures. No relevant disclosures. Objectives. Recognize key elements of the clinical history, diagnostic evaluation, and treatment methodology for pediatric demyelinating disorders. v. 3.2 T-type channel activity. Robin N. Stringer, . Bohumila. . Jurkovicova-Tarabova. , Sun Huang, Omid Haji-. Ghassemi. , . Romane. . Idoux. ,. Anna . Liashenko. , Ivana A. Souza, . Yuriy. . Rzhepetskyy. Page 1 of 8 AMYOTROPHIC LATERAL SCLEROSIS (LOU GEHRIG'S DISEASE) DISABILITY BENEFITS QUESTIONNAIREPATIENT/VETERAN'S SOCIAL SECURITY NUMBERNAME OF PATIENT/VETERAN Note - The Veteran is applying to the (ALS; also known as Lou Gehrigs disease and motor neuron disease) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor Dr A O’Connor, Dr P O’Brien. Medical Department, Naas General Hospital. 21-IMRIM-30. Introduction. Multiple sclerosis (MS), an autoimmune disease of the central nervous system (CNS). Patients may experience a gradual loss of visual, motor and sensory functions. Standardized definitions for the clinical courses of MS include relapsing-remitting, secondary progressive, primary progressive, and progressive relapsing . Download PDF Natural Multiple Sclerosis Treatment System™ eBook by Dr. Gary M. Levin - a natural, holistic approach to improve and manage multiple sclerosis through specialized nutrition and vitamin supplementation. From observation to intervention. Team members. :. Efrat Neter. 1. , Efrat Esterkin-Hubner. 2. , Anat Wolkowitz. 2. , Lea Glass-Marmor. 2. , Ariel Miller. 2,4. 1 . Ruppin. Academic Center, Israel. 2 .